Chimin Health Management Co., Ltd. announced that it has received CNY 241.246533 million in funding from Shanghai Chunda Asset Management Co., Ltd., Shenzhen Zongguan Capital Management Co., Ltd., Caitong Fund Management Co., Ltd., and other investors
April 11, 2021
Share
On April 12, 2021, Chimin Health Management Co., Ltd. (SHSE:603222) closed the transaction. The company issued 20,743,468 shares at the price of CNY 11.63 per share for gross proceeds of CNY 241,246,532.84 where issuance costs (excluding tax) are CNY 7,142,230.84 and net proceeds of CNY 234,104,302. Shanghai Chunda Asset Management Co., Ltd. acquired 1,289,767 shares, Zhang Qilong acquired 1,719,690 shares, Zhou Qian acquired 2,579,535 shares, Lin Jintao acquired 171,969 shares, Shen Puqun acquired 1,600,000 shares, Fan Dashuai acquired 429,922 shares, Sun Yanping acquired 342,000 shares, Xu Yurong acquired 515,907 shares, Ma Yun acquired 859,845 shares, Lin Zhonghai acquired 600,000 shares, Shenzhen Zongguan Capital Management Co., Ltd. acquired 8,125,537 shares, Rui Xuefeng acquired 278,000 shares, Caitong Fund Management Co., Ltd.'s Caitong Fund-Zhongyuan Securities Co., Ltd.-Caitong Fund Tianxi Dingzeng No. 66 Single Asset Management Plan acquired 859,845shares, Caitong Fund-Li Shaojun-Caitong Fund Yuquan No. 919 Single Asset Management Plan acquired 472,914 shares, Caitong Fund-Xuanling Enhanced No. 21 Private Securities Investment Fund-Caitong Fund Xuanling No. 1 Asset Management Plan acquired 42,992 shares, Caitong Fund-Taoxiong Sun-Caitong Fund Yuquan No. 963 Single Asset Management Plan acquired 42,992 shares, Caitong Fund-Liao Zhiwen-Caitong Fund Anji No. 112 Single Asset Management Plan acquired 81,685 shares, and Liu Xiangfeng acquired 730,868 shares.
Chimin Health Management Co., Ltd., formerly Zhejiang Chimin Pharmaceutical CO., Ltd, is primarily engaged in the research, development, manufacture and sale of infusion and injection and puncture machinery products. The Company primarily produces Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, as well as injection and puncture machinery products, including safety syringe, sterile syringes and infusion sets. The Company distributes its products within domestic market and to overseas markets.
Chimin Health Management Co., Ltd. announced that it has received CNY 241.246533 million in funding from Shanghai Chunda Asset Management Co., Ltd., Shenzhen Zongguan Capital Management Co., Ltd., Caitong Fund Management Co., Ltd., and other investors